EDWARD DAINESI: Open Payments
NPI 1821075417 · MC MURRAY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,445 in 182 payments from 25 companies in 2025. Trend: 2023 $2,642 · 2024 $2,850 · 2025 $3,445
Food & beverage: $3,445
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $846 |
| Novo Nordisk Inc | 24 | $392 |
| Daiichi Sankyo Inc. | 17 | $375 |
| PFIZER INC. | 25 | $335 |
| GlaxoSmithKline, LLC. | 11 | $218 |
| Teva Pharmaceuticals USA, Inc. | 10 | $207 |
| Lilly USA, LLC | 12 | $205 |
| Lundbeck LLC | 7 | $188 |
| Abbott Laboratories | 8 | $149 |
| Amgen Inc. | 5 | $73 |
Products named: INJECTAFER, QULIPTA, VRAYLAR, REXULTI, AUSTEDO XR, UBRELVY, FREESTYLE LIBRE 3, MOUNJARO.
Industry payments across PA — which companies pay providers there.
